Clinical trial
Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD): a Type II Hybrid Implementation-Effectiveness Trial
NCT07243886 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD): a Type II Hybrid Implementation-Effectiveness Trial
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 30, 2026
- Completion date
- December 31, 2030
- Enrollment
- 864 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
gestational diabetes, hypertensive disorder of pregnancy